These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16224535)

  • 1. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
    Morris ES; MacDonald KP; Rowe V; Banovic T; Kuns RD; Don AL; Bofinger HM; Burman AC; Olver SD; Kienzle N; Porcelli SA; Pellicci DG; Godfrey DI; Smyth MJ; Hill GR
    J Clin Invest; 2005 Nov; 115(11):3093-103. PubMed ID: 16224535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
    Morris ES; MacDonald KP; Hill GR
    Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
    Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.
    Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL
    Blood; 1999 Jun; 93(12):4071-8. PubMed ID: 10361103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor treatment with a multipegylated G-CSF maximizes graft-versus-leukemia effects.
    Banovic T; MacDonald KP; Markey KA; Morris ES; Kuns RD; Varelias A; Hill GR
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):126-30. PubMed ID: 19135951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.
    Weiss L; Or R; Slavin S; Naparstek E; Reich S; Abdul-Hai A
    Cancer Immunol Immunother; 2004 Apr; 53(4):358-62. PubMed ID: 14605765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.
    Arbez J; Saas P; Lamarthée B; Malard F; Couturier M; Mohty M; Gaugler B
    Cytotherapy; 2015 Jul; 17(7):948-55. PubMed ID: 25813681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
    Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E
    Front Immunol; 2021; 12():625165. PubMed ID: 33777007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt-3L Expansion of Recipient CD8α
    Markey KA; Kuns RD; Browne DJ; Gartlan KH; Robb RJ; Martins JP; Henden AS; Minnie SA; Cheong M; Koyama M; Smyth MJ; Steptoe RJ; Belz GT; Brocker T; Degli-Esposti MA; Lane SW; Hill GR
    Clin Cancer Res; 2018 Apr; 24(7):1604-1616. PubMed ID: 29367429
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donors.
    Vela-Ojeda J; Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Stem Cells Dev; 2005 Jun; 14(3):310-6. PubMed ID: 15969626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human Valpha24+Vbeta11+NKT cells.
    Crough T; Nieda M; Nicol AJ
    J Immunol; 2004 Oct; 173(8):4960-6. PubMed ID: 15470038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H
    Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT.
    Su YC; Li SC; Hsu CK; Yu CC; Lin TJ; Lee CY; Liao HF
    Bone Marrow Transplant; 2012 Jan; 47(1):73-81. PubMed ID: 21358682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.
    MacDonald KP; Le Texier L; Zhang P; Morris H; Kuns RD; Lineburg KE; Leveque L; Don AL; Markey KA; Vuckovic S; Bagger FO; Boyle GM; Blazar BR; Hill GR
    J Immunol; 2014 Apr; 192(7):3180-9. PubMed ID: 24585878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.